Investment
Features
FeesSafety
Academy
More
Pluang+

Bitwise's NEAR ETF approved to list on NYSE Arca, offering exposure with 0.75% fee and staking strategy.

Market News
25 Sep 2026
Tokenpost
View Source
Bullish
Bitwise's NEAR ETF approved to list on NYSE Arca, offering exposure with 0.75% fee and staking strategy.

Bitwise's NEAR exchange-traded fund (ETF) has received approval to list on the NYSE Arca under the ticker NRR. The fund aims to provide investors exposure to the NEAR cryptocurrency by holding and staking 100% of its NEAR assets to potentially earn additional returns. The ETF charges a management fee of 0.75%. While the listing approval is confirmed, the Securities and Exchange Commission (SEC) has not yet approved or disapproved the offering. The fund's initial net assets were $200 as of July 28, but the launch date has not been announced.

Bitwise's NEAR ETF listing approval provides context for cryptocurrency market activity. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Sep 25, 2026 17:22 WIB: 46 of 50 major cryptocurrencies rose while 3 fell. Notable movers include KSM at Rp83.886 (+8.41%), EOS at Rp12.649 (+8.13%), and COTI at Rp298 (+7.81%).

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
2 hours ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
2 hours ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
2 hours ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App